Ferring Signs a Research Colllaboration with Evotec to Develop Novel Small Molecule Therapies

 Ferring Signs a Research Colllaboration with Evotec to Develop Novel Small Molecule Therapies

Ferring Signs a Research Colllaboration with Evotec to Develop Novel Small Molecule Therapies

Shots:

  • Evotec to provide Ferring its discovery and development platform to develop novel therapies in fertility and gynecology and will also receive upfronts and milestone payments
  • The multi-target and multi-year collaboration is providing PDC & IND candidates for gynaecological conditions
  • The collaboration focusses on developing and providing therapies for families and with a motive to advance reproductive medicine & women’s health

Click here to read full press release/ article | Ref:  Ferring Pharmaceuticals | Image:  The Pharma Letter

Shiwani Sharma

Shiwani Sharma is a Senior Editor at PharmaShots. She has in-depth knowledge of lifesciences industry including pharma and biotech sectors. She also covers news in field of Digital Health, Medtech and regulatory approvals from the US FDA, EU, and other global regulatory bodies in the industry. Additionally, she also writes Whitepapers, analysis reports, blogs on pharma and biotech industry. She is graduate in Biotechnology. She can be contacted on shiwani@pharmashots.com

Related post